ArticleTranslational lung cancer research2026
Prognostic impact of immune-related adverse events in non-completers of durvalumab consolidation therapy for non-small cell lung cancer: a single-center retrospective cohort study.
Noriyuki Ebi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.